A stronger than expected gain in consumer confidence lifted the markets during the midday with the Dow soaring 109 points to 16,385. Nasdaq added 10 points to 4237.
On the upside
Galectin Therapeutics (Nasdaq: GALT) will report first cohort results from a Phase 1 clinical study of GR-MD-02 in treating fatty liver disease with advanced fibrosis on Monday, March 31.
3D Analytics initiated coverage of Arotech (Nasdaq: ARTX) with a Buy rating and a $16 price target.
24/7 Wall Street wrote that a fair valuation of Plug Power (Nasdaq: PLUG) could be between $7.00 and $17.50 per share.
On the downside
Profit taking sank shares of Microvision (Nasdaq: MVIS).
Shares of Wet Seal (Nasdaq: WTSL) extended its losses.
Robbins Arroyo filed a class action lawsuit against Geron (Nasdaq: GERN) on behalf of an investor alleging securities fraud.
In the broad market, advancing issues outpaced decliners by a margin of 5 to 4 on the NYSE while decliners edged out advancers by 10 to 9 on Nasdaq. The broader S&P 500 gained 8 points to 1866. Bitcoin edged up $0.52 or 0.09%% to $577.53.
